A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

NCT00712504 ·Status: COMPLETED ·Phase: PHASE1

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

NCT00853125 ·Status: TERMINATED ·Phase: PHASE2

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

NCT00583063 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

NCT00499135 ·Status: COMPLETED ·Phase: PHASE1

SU011248 in Advanced Hepatocellular Carcinoma

NCT00361309 ·Status: COMPLETED ·Phase: PHASE2

Sunitinib in Refractory Adrenocortical Carcinoma

NCT00453895 ·Status: COMPLETED ·Phase: PHASE2

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974 ·Status: COMPLETED ·Phase: PHASE2

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

NCT00528619 ·Status: COMPLETED ·Phase: PHASE1

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

NCT02068586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

NCT00514137 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

NCT00054886 ·Status: COMPLETED ·Phase: PHASE2

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

NCT00083889 ·Status: COMPLETED ·Phase: PHASE3

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

NCT04535687 ·Status: COMPLETED ·Phase: PHASE2

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

NCT00498966 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

NCT00001570 ·Status: COMPLETED ·Phase: PHASE1

A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

NCT02386111 ·Status: TERMINATED ·Phase: PHASE1

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

NCT00130897 ·Status: APPROVED_FOR_MARKETING

PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases

NCT06380881 ·Status: COMPLETED ·Phase: PHASE1

AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib

NCT00853372 ·Status: COMPLETED ·Phase: PHASE2

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

NCT02187042 ·Status: COMPLETED

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

NCT00474994 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer

NCT04349280 ·Status: TERMINATED ·Phase: PHASE1

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

NCT05733715 ·Status: RECRUITING ·Phase: EARLY_PHASE1